DOSSIER · 13F Holders · Q1 2026Mega-capCrowded
AGMB
AgomAb Therapeutics NV ADR
26 institutions still hold AgomAb Therapeutics NV ADR as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 00860C102·26 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
26 institutions reported AGMB in Q1 2026. EQT Fund Management S.a r.l. leads at 22.3% of the visible book. +15 net new institutions vs prior quarter — accumulation reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 2
6 more holders available. Log in →